Results and Corporate Presentations

Interim results for the six months ended 30 June 2021 22 September 2021

Preliminary results for the year ended 31 December 2020 15 April 2021

Interim results for the six months ended 30 June 2020 17 September 2020

Preliminary results for the year ended 31 December 2019 6 May 2020

Interim results for the six months ended 30 June 2019 4 September 2019

Preliminary results for the year ended 31 December 2018 14 March 2019

Analyst Presentation: Interim results for the six months ended 30 June 2018 13 September 2018

Analyst Presentation: Oxford BioMedica and Axovant licence agreement 21 June 2018

Preliminary results for the year ended 31 December 2017 15 March 2018

Analyst Presentation: Oxford BioMedica and Bioverativ Collaboration 15 February 2018

Jefferies Presentation 15 November 2017

Analyst Presentation: Interim results for the six months ended 30 June 2017 16 August 2017